MedPath

Lignospan Standard

LIGNOSPAN FORTE (Lidocaine HCl 2% and Epinephrine 1:50,000 Injection) LIGNOSPAN STANDARD (Lidocaine HCl 2% and Epinephrine 1:100,000 Injection)(Lidocaine hydrochloride and epinephrine injection, USP)

Approved
Approval ID

82e7d9d8-bad8-4dac-8e2c-29e834fc6dbf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 15, 2011

Manufacturers
FDA

Novocol Pharmaceutical of Canada, Inc.

DUNS: 201719960

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine Hydrochloride and Epinephrine Bitartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51004-1095
Application NumberANDA088390
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine Hydrochloride and Epinephrine Bitartrate
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateOctober 1, 2011
FDA Product Classification

INGREDIENTS (7)

Lidocaine HydrochlorideActive
Quantity: 20 mg in 1 mL
Code: V13007Z41A
Classification: ACTIB
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Sodium ChlorideInactive
Quantity: 6.5 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
Edetate DisodiumInactive
Quantity: 0.25 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
Epinephrine BitartrateActive
Quantity: 0.01 mg in 1 mL
Code: 30Q7KI53AK
Classification: ACTIM
Potassium MetabisulfiteInactive
Quantity: 1.2 mg in 1 mL
Code: 65OE787Q7W
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lignospan Standard - FDA Drug Approval Details